美国FDA《药物开发中新方法应用的一般考虑》指南草案解读
赵曼曼, 周晓冰
Interpretation of FDA Draft Guidance: General Considerations for the Use of New Approach Methodologies in Drug Development
ZHAO Man-man, ZHOU Xiao-bing
中国食品药品监管
.
2026, (8): 58
-65
.
DOI: 10.3969/j.issn.1673-5390.2026.08.006
京公网安备11010802023381号